S&P 500   4,975.51
DOW   38,563.80
QQQ   427.32
Booking stock is the discounted growth story in travel stocks
Americans Now Favor Gold Over Stocks as an Investment Vehicle (Ad)
3 E-VTOL stocks: Which ones can fly higher in 2024?
Capital One's bid for Discover carries expectation that Americans won't slow credit card use
Is Gold Really Boring? (Ad)
Walmart’s uptrend is intact; buy it when it dips
Americans' reliance on credit cards is the key to Capital One's bid for Discover
Is Gold Really Boring? (Ad)
U.S. casinos won $66.5B in 2023, their best year ever as gamblers showed no economic fear
How major US stock indexes fared Tuesday, 2/20/2024
S&P 500   4,975.51
DOW   38,563.80
QQQ   427.32
Booking stock is the discounted growth story in travel stocks
Americans Now Favor Gold Over Stocks as an Investment Vehicle (Ad)
3 E-VTOL stocks: Which ones can fly higher in 2024?
Capital One's bid for Discover carries expectation that Americans won't slow credit card use
Is Gold Really Boring? (Ad)
Walmart’s uptrend is intact; buy it when it dips
Americans' reliance on credit cards is the key to Capital One's bid for Discover
Is Gold Really Boring? (Ad)
U.S. casinos won $66.5B in 2023, their best year ever as gamblers showed no economic fear
How major US stock indexes fared Tuesday, 2/20/2024
S&P 500   4,975.51
DOW   38,563.80
QQQ   427.32
Booking stock is the discounted growth story in travel stocks
Americans Now Favor Gold Over Stocks as an Investment Vehicle (Ad)
3 E-VTOL stocks: Which ones can fly higher in 2024?
Capital One's bid for Discover carries expectation that Americans won't slow credit card use
Is Gold Really Boring? (Ad)
Walmart’s uptrend is intact; buy it when it dips
Americans' reliance on credit cards is the key to Capital One's bid for Discover
Is Gold Really Boring? (Ad)
U.S. casinos won $66.5B in 2023, their best year ever as gamblers showed no economic fear
How major US stock indexes fared Tuesday, 2/20/2024
S&P 500   4,975.51
DOW   38,563.80
QQQ   427.32
Booking stock is the discounted growth story in travel stocks
Americans Now Favor Gold Over Stocks as an Investment Vehicle (Ad)
3 E-VTOL stocks: Which ones can fly higher in 2024?
Capital One's bid for Discover carries expectation that Americans won't slow credit card use
Is Gold Really Boring? (Ad)
Walmart’s uptrend is intact; buy it when it dips
Americans' reliance on credit cards is the key to Capital One's bid for Discover
Is Gold Really Boring? (Ad)
U.S. casinos won $66.5B in 2023, their best year ever as gamblers showed no economic fear
How major US stock indexes fared Tuesday, 2/20/2024

Zimmer Biomet (ZBH) Short Interest Ratio & Short Volume

$124.98
+0.27 (+0.22%)
(As of 02/20/2024 ET)

Zimmer Biomet Short Interest Data

Current Short Volume
4,300,000 shares
Previous Short Volume
4,110,000 shares
Change Vs. Previous Month
+4.62%
Dollar Volume Sold Short
$540.08 million
Short Interest Ratio / Days to Cover
2.4
Last Record Date
January 31, 2024
Outstanding Shares
208,980,000 shares
Percentage of Shares Shorted
2.06%
Today's Trading Volume
1,388,775 shares
Average Trading Volume
1,741,293 shares
Today's Volume Vs. Average
80%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Zimmer Biomet ?

Sign up to receive the latest short interest report for Zimmer Biomet and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ZBH Short Interest Over Time

ZBH Days to Cover Over Time

ZBH Percentage of Float Shorted Over Time


Zimmer Biomet Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/31/20244,300,000 shares $540.08 million +4.6%N/A2.4 $125.60
1/15/20244,110,000 shares $505.82 million -3.3%N/A2.3 $123.07
12/31/20234,250,000 shares $517.23 million +32.8%N/A2.4 $121.70
12/15/20233,200,000 shares $380.13 million +42.2%N/A1.7 $118.79
11/30/20232,250,000 shares $261.68 million -9.6%N/A1.3 $116.30
11/15/20232,490,000 shares $275.15 million +13.2%N/A1.4 $110.50
10/31/20232,200,000 shares $229.70 million +4.3%N/A1.3 $104.41
10/15/20232,110,000 shares $220.07 million -23.0%N/A1.2 $104.30
9/30/20232,740,000 shares $307.48 million +22.9%N/A1.7 $112.22
9/15/20232,230,000 shares $270.52 million +2.8%N/A1.5 $121.31
8/31/20232,170,000 shares $258.49 million -20.2%N/A1.4 $119.12
8/15/20232,720,000 shares $333.17 million -12.5%N/A1.8 $122.49
7/31/20233,110,000 shares $429.65 million -11.7%N/A2.2 $138.15
7/15/20233,520,000 shares $501.14 million -9.5%N/A2.5 $142.37
6/30/20233,890,000 shares $566.11 million +2.1%N/A2.7 $145.53
6/15/20233,810,000 shares $543.23 million +27.0%N/A2.7 $142.58
5/31/20233,000,000 shares $382.02 million +11.9%1.4%2.2 $127.34
5/15/20232,680,000 shares $366.68 million -17.3%1.3%2.2 $136.82
4/30/20233,240,000 shares $448.55 million -6.1%1.6%2.6 $138.44
4/15/20233,450,000 shares $456.68 million +4.9%N/A2.7 $132.37
3/31/20233,290,000 shares $425.07 million -1.8%N/A2.4 $129.20
3/15/20233,350,000 shares $419.62 million +6.0%N/A2.4 $125.26
2/28/20233,160,000 shares $391.43 million +5.0%N/A2.1 $123.87
2/15/20233,010,000 shares $380.80 million +26.5%N/A2.1 $126.51
1/31/20232,380,000 shares $303.07 million +1.7%N/A1.7 $127.34
1/15/20232,340,000 shares $288.71 million -22.3%N/A1.7 $123.38
12/30/20223,010,000 shares $383.78 million -0.3%N/A2.3 $127.50
12/15/20223,020,000 shares $383.60 million +8.2%N/A2.5 $127.02
11/30/20222,790,000 shares $335.08 million +23.5%N/A2.3 $120.10
11/15/20222,260,000 shares $260.17 million -16.6%N/A2 $115.12
10/31/20222,710,000 shares $307.18 million -2.2%N/A2.5 $113.35
10/15/20222,770,000 shares $296.14 million +3.4%N/A2.6 $106.91
9/30/20222,680,000 shares $280.19 million +5.1%N/A2.5 $104.55
9/15/20222,550,000 shares $295.21 million +3.7%N/A2.4 $115.77
8/31/20222,460,000 shares $261.55 million -1.6%N/A2.2 $106.32
8/15/20222,500,000 shares $291.83 million +4.2%N/A2.2 $116.73
7/31/20222,400,000 shares $264.94 million -10.1%N/A2 $110.39
7/15/20222,670,000 shares $276.37 million -0.7%N/A2.1 $103.51
6/30/20222,690,000 shares $282.61 million +4.7%N/A2.1 $105.06
6/15/20222,570,000 shares $274.91 million +19.5%1.3%1.8 $106.97













ZBH Short Interest - Frequently Asked Questions

What is Zimmer Biomet's current short interest?

Short interest is the volume of Zimmer Biomet shares that have been sold short but have not yet been closed out or covered. As of January 31st, traders have sold 4,300,000 shares of ZBH short. Learn More on Zimmer Biomet's current short interest.

What is a good short interest ratio for Zimmer Biomet?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ZBH shares currently have a short interest ratio of 2.0. Learn More on Zimmer Biomet's short interest ratio.

Which institutional investors are shorting Zimmer Biomet?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Zimmer Biomet: GTS Securities LLC, Wolverine Trading LLC, Paloma Partners Management Co, Parallax Volatility Advisers L.P., Caas Capital Management LP, Citadel Advisors LLC, Royal Bank of Canada, Capital Fund Management S.A., PEAK6 Investments LLC, Capstone Investment Advisors LLC, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Zimmer Biomet's short interest increasing or decreasing?

Zimmer Biomet saw a increase in short interest during the month of January. As of January 31st, there was short interest totaling 4,300,000 shares, an increase of 4.6% from the previous total of 4,110,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Zimmer Biomet's short interest compare to its competitors?

Here is how the short interest of companies in the sector of "medical" compare to Zimmer Biomet: STERIS plc (2.18%), Smith & Nephew plc (0.33%), Edwards Lifesciences Co. (1.67%), Cardinal Health, Inc. (2.83%), ResMed Inc. (4.30%), Molina Healthcare, Inc. (2.69%), argenx SE (2.01%), ICON Public Limited (2.48%), Align Technology, Inc. (2.04%), West Pharmaceutical Services, Inc. (1.58%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.48 billion), General Motors ($3.85 billion), Charter Communications, Inc. ($3.38 billion), Occidental Petroleum Co. ($3.00 billion), Super Micro Computer, Inc. ($2.66 billion), Tractor Supply ($2.37 billion), Coinbase Global, Inc. ($2.25 billion), Moderna, Inc. ($2.11 billion), Royal Caribbean Cruises Ltd. ($2.06 billion), and Floor & Decor Holdings, Inc. ($1.67 billion). View all of the most shorted stocks.

What does it mean to sell short Zimmer Biomet stock?

Short selling ZBH is an investing strategy that aims to generate trading profit from Zimmer Biomet as its price is falling. ZBH shares are trading up $0.27 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Zimmer Biomet?

A short squeeze for Zimmer Biomet occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ZBH, which in turn drives the price of the stock up even further.

How often is Zimmer Biomet's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ZBH, twice per month. The most recent reporting period available is January, 31 2024.



More Short Interest Resources from MarketBeat

This page (NYSE:ZBH) was last updated on 2/21/2024 by MarketBeat.com Staff